Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B

Journal of Molecular and Cellular Cardiology
A VujicR S Foo

Abstract

Differential DNA methylation exists in the epigenome of end-stage failing human hearts but whether it contributes to disease progression is presently unknown. Here, we report that cardiac specific deletion of Dnmt3b, the predominant DNA methyltransferase in adult mouse hearts, leads to an accelerated progression to severe systolic insufficiency and myocardial thinning without a preceding hypertrophic response. This was accompanied by widespread myocardial interstitial fibrosis and myo-sarcomeric disarray. By targeted candidate gene quantitative RT-PCR, we discovered an over-activity of cryptic splice sites in the sarcomeric gene Myh7, resulting in a transcript with 8 exons missing. Moreover, a region of differential methylation overlies the splice site locus in the hearts of the cardiac-specific conditional knockout (CKO) mice. Although abundant and complex forms of alternative splice variants have been reported in diseased hearts and the contribution of each remains to be understood in further detail, our results demonstrate for the first time that a link may exist between alternative splicing and the cardiac epigenome. In particular, this gives the novel evidence whereby the loss of an epigenome modifier promotes the developm...Continue Reading

References

Apr 4, 2006·Molecular and Cellular Biology·Haijiang LinRudolf Jaenisch
Mar 28, 2008·The New England Journal of Medicine·Joseph A Hill, Eric N Olson
May 9, 2008·Nature Reviews. Genetics·Miho M Suzuki, Adrian Bird
Jun 26, 2008·JAMA : the Journal of the American Medical Association·Hans T BjornssonAndrew P Feinberg
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Auinash KalsotraThomas A Cooper
Jan 20, 2009·Mechanisms of Ageing and Development·Valentina BollatiAndrea Baccarelli
Feb 24, 2009·Biochimica Et Biophysica Acta·Mikko P TurunenSeppo Ylä-Herttuala
Apr 4, 2009·Science·Olaf BergmannJonas Frisén
Feb 4, 2010·Circulation. Cardiovascular Genetics·Sek Won KongWilliam T Pu
Feb 6, 2010·Science·Reini F LucoTom Misteli
Mar 20, 2010·Genes & Development·Auinash KalsotraThomas A Cooper
Sep 3, 2010·The Journal of Clinical Investigation·Polakit TeekakirikulJonathan G Seidman
Dec 16, 2010·Circulation. Cardiovascular Genetics·Andrea BaccarelliEmelia J Benjamin
May 4, 2011·The Journal of Clinical Investigation·Norimichi KoitabashiDavid A Kass
Oct 26, 2011·Circulation·Mehregan MovassaghRoger S-Y Foo
Feb 4, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lee SiggensRoger Foo
Mar 2, 2012·European Journal of Human Genetics : EJHG·Erica LanaAlbertina De Sario
Oct 5, 2012·Genome Biology·Syed HaiderRoger Foo
Jan 3, 2013·The Journal of Clinical Investigation·Elizabeth M McNallyMegan J Puckelwartz

❮ Previous
Next ❯

Citations

Nov 19, 2015·International Journal of Molecular Sciences·Zodwa DlaminiRodney Hull
Nov 25, 2016·Journal of Cellular Physiology·Asish K GhoshDouglas E Vaughan
Sep 22, 2018·Physiological Genomics·Caryn Carson, Heather A Lawson
May 22, 2019·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Dimple PrasherRaja B Singh
Jun 17, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiefan FangChristopher C Wendler
Aug 23, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Peng ZhangJi-Min Cao
Feb 14, 2020·Laboratory Investigation; a Journal of Technical Methods and Pathology·Tong-Tong WuDan Lu
Jul 16, 2020·International Journal of Molecular Sciences·Amela Jusic On Behalf Of The Eu-CardioRNA Cost Action
Apr 25, 2020·Physiological Reviews·Roberto PapaitGianluigi Condorelli
Sep 17, 2020·Journal of Biochemical and Molecular Toxicology·Dongmei SuXu Ma
Apr 17, 2020·Heart Failure Reviews·Hao LeiDanyan Xu
Dec 3, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Adam Russell-HallinanJohn A Baugh
Dec 8, 2020·Oxidative Medicine and Cellular Longevity·Kai WangLuyu Zhou
Feb 15, 2021·Journal of Molecular and Cellular Cardiology·Alexandra MadsenJustus Stenzig
Jun 14, 2021·Journal of Molecular and Cellular Cardiology·Luis AlgecirasAna V Villar
Jul 16, 2021·Frontiers in Cell and Developmental Biology·Hui XuYou-Shuo Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Jian-Fu ChenDa-Zhi Wang
The New England Journal of Medicine
Dale G Renlund, Abdallah G Kfoury
Molecular and Cellular Biology
Haijiang LinRudolf Jaenisch
© 2021 Meta ULC. All rights reserved